Federal contract award

75F40124P00335

MASS SPECTROMETRY ANALYSIS OF SARS-COV-2 ANTIBODY REPERTOIRE IN 145 HUMAN PLASMA SAMPLES

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeFDA OFFICE OF ACQ GRANT SVCS
NAICS621511 — Medical Laboratories
PSCB504 — Chemical/Biological Studies and Analysis
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$76.7K
Current contract value$76.7K
Potential contract value / ceiling$76.7K
Start dateAug 27, 2024
Current end dateFeb 27, 2025
Potential end dateFeb 27, 2025
Latest award activityJan 22, 2026
Source loadedSep 19, 2026

Funding and modification history

Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jan 22, 2026P00002$-1.1KTHE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE FUNDS AND CLOSE OUT THE CONTRACT.
Dec 4, 2024P00001$0MASS SPECTROMETRY ANALYSIS OF SARS-COV-2 ANTIBODY REPERTOIRE IN 145 HUMAN PLASMA SAMPLES

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
Nick SartainContactnick.sartain@fda.hhs.gov
8705437370
SourceJun 4, 2024

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.